Joseph Edelman, Perceptive Advisors Continue Bullish Streak in AcelRX Pharmaceuticals

Joseph Edelman’s fund Perceptive Advisors continues its bullish streak on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) disclosing increasing its position to over 6.57 million shares, after reporting buying a total of 515,700 shares last week. This time, Perceptive acquired 200,000 shares, the price varying around the $6.50 mark.

AcelRx Pharmaceuticals Inc

Disclosure: none

Recommended Reading:

Mario Gabelli, Gamco Disclose Moves Into Superior Industries International, Cutera and Bel Fuse

Why Did Brian Bares Significantly Cut His Stake in American Public Education?

Martin Whitman’s Third Avenue Cuts Exposure at Stanley Furniture